• New Developments in the Understanding of Epilepsy and the Application of Antiepileptic Therapies
  • Brown Bag Consult: I'm Not Feeling Well
  • Pharmacy Sues DEA for Seizing Its Drugs
  • Confronting the Challenge of Health Care–Associated Infections
  • Checking Long-Term Care Blister Packs and Bingo Cards
  • Can You Read These Rxs? (November 2014)

Breaking News

FDA Approves New Antibacterial Drug to Treat UTIs, Intra-Abdominal Infections
A new FDA-approved drug could help treat complicated intra-abdominal infections and complicated urinary tract infections among adults.
The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.
Olaparib treats women with advanced ovarian cancer associated with defective BRCA genes.
The majority of fatal poisonings in 2012 resulted from prescription drug use.
A mother in the United Kingdom started to worry about her 13-month-old daughter when she noticed Mollie staring straight ahead in the car and not responding to her name.
The FDA has approved the first pathogen reduction system for the preparation of plasma by blood establishments.
A new FDA approval may soon help children with allergies seek relief from nasal symptoms.

From the Issue

Previous TabNext Tab
Strategic Alliance Partners
Latest Issues